Search research articles
Contact Us
Filters
Showing results (21-30 of 112) with videos related to
Page
of 12
Sort By:
Cancer Immunology, Immunotherapy : CII
|
April 1, 1997
Prevention of superantigen-induced tolerance in vivo by interleukin-2 treatment
H Belfrage, M Dohlsten, G Hedlund, et al.
Cancer Immunology, Immunotherapy : CII
|
January 1, 1993
Superantigen-based tumor therapy: in vivo activation of cytotoxic T cells
G Hedlund, M Dohlsten, C Petersson, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 1, 1987
Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells
T Kalland, H Belfrage, P Bhiladvala, et al.
Cancer Immunology, Immunotherapy : CII
|
January 1, 1991
Bacterial superantigens as anti-tumour agents: induction of tumour cytotoxicity in human lymphocytes by staphylococcal enterotoxin A
P A Lando, G Hedlund, M Dohlsten, et al.
Neuroreport
|
June 19, 1998
The immune modulator Linomide prevents neuronal death in injured peripheral nerves of the mouse
P A Ekström, G Hedlund, J Karlsson, et al.
Scandinavian Journal of Immunology
|
December 11, 1997
Linomide enhances apoptosis in CD4+CD8+ thymocytes
A C Harring, Z Xu, G Andersson, et al.
European Journal of Immunology
|
January 1, 1995
Distinct splicing of CD45 mRNA in activated rat gamma delta cytotoxic T lymphocytes
J Hansson, M Dohlsten, H O Sjögren, et al.
Scandinavian Journal of Immunology
|
October 1, 1986
Evidence for the existence of W3/13+ monocytes in the rat
G Hedlund, S Segrén, B Jansson, et al.
Scandinavian Journal of Immunology
|
December 1, 1988
Inhibitory effects of histamine on interleukin 2 and gamma interferon production of different human T helper cell subsets
M Dohlsten, G Hedlund, H O Sjögren, et al.
European Journal of Immunology
|
August 1, 1988
Two subsets of human CD4+ T helper cells differing in kinetics and capacities to produce interleukin 2 and interferon-gamma can be defined by the Leu-18 and UCHL1 monoclonal antibodies
M Dohlsten, G Hedlund, H O Sjögren, et al.
Page
of 12
Search research articles
Search
Showing results (21-30 of 112) with videos related to
Sort By:
Page
of 12
Cancer Immunology, Immunotherapy : CII
|
April 1, 1997
Prevention of superantigen-induced tolerance in vivo by interleukin-2 treatment
H Belfrage, M Dohlsten, G Hedlund, et al.
Cancer Immunology, Immunotherapy : CII
|
January 1, 1993
Superantigen-based tumor therapy: in vivo activation of cytotoxic T cells
G Hedlund, M Dohlsten, C Petersson, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 1, 1987
Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells
T Kalland, H Belfrage, P Bhiladvala, et al.
Cancer Immunology, Immunotherapy : CII
|
January 1, 1991
Bacterial superantigens as anti-tumour agents: induction of tumour cytotoxicity in human lymphocytes by staphylococcal enterotoxin A
P A Lando, G Hedlund, M Dohlsten, et al.
Neuroreport
|
June 19, 1998
The immune modulator Linomide prevents neuronal death in injured peripheral nerves of the mouse
P A Ekström, G Hedlund, J Karlsson, et al.
Scandinavian Journal of Immunology
|
December 11, 1997
Linomide enhances apoptosis in CD4+CD8+ thymocytes
A C Harring, Z Xu, G Andersson, et al.
European Journal of Immunology
|
January 1, 1995
Distinct splicing of CD45 mRNA in activated rat gamma delta cytotoxic T lymphocytes
J Hansson, M Dohlsten, H O Sjögren, et al.
Scandinavian Journal of Immunology
|
October 1, 1986
Evidence for the existence of W3/13+ monocytes in the rat
G Hedlund, S Segrén, B Jansson, et al.
Scandinavian Journal of Immunology
|
December 1, 1988
Inhibitory effects of histamine on interleukin 2 and gamma interferon production of different human T helper cell subsets
M Dohlsten, G Hedlund, H O Sjögren, et al.
European Journal of Immunology
|
August 1, 1988
Two subsets of human CD4+ T helper cells differing in kinetics and capacities to produce interleukin 2 and interferon-gamma can be defined by the Leu-18 and UCHL1 monoclonal antibodies
M Dohlsten, G Hedlund, H O Sjögren, et al.
Page
of 12